| Application no. and date | 09721703.8 (espacenet) (Federated) (European Patent Register), 20090312 | | Patent/reg. no. and date | DK/EP 2278960, 20161130 | | Publication date | 20110202 | | Priority no. and date | WO PCT/IB2008/050995, 20080317 | | EP pub. no. and date |
EP 2278960 20110202 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd., Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | P60664DK01 | | Inventor | SCHERZ, Michael, Eigenweg 11
CH-4107 Ettingen, CH,
NAYLER, Oliver, Hangstrasse 38
CH-4144 Arlesheim, CH,
STEINER, Beat, Zugerstrasse 3
CH-4143 Dornach, CH,
BROSSARD, Patrick, Spitzwaldstrasse 104
CH-4123 Allschwil, CH,
DINGEMANSE, Jasper, Lützelbachweg 28
CH-4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/00 (2006.01) , A61K 31/426 (2006.01) , A61P 9/06 (2006.01) | | Title | DOSISREGIMEN TIL EN SELEKTIV SIP1 RECEPTORAGONIST | | Int. application no. | IB2009051030 | | Int. publication no. | WO2009115954 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
